Universe Pharmaceuticals INC Holds 2025 Annual Shareholder Meeting
Ticker: UPC · Form: 6-K · Filed: Sep 3, 2025 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Sep 3, 2025 |
| Risk Level | low |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $11.25, $0.00001, $11.24999, $134,287,453.13338, $20,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, filing-update
TL;DR
Universe Pharma held its shareholder meeting on Sept 2nd, all good.
AI Summary
Universe Pharmaceuticals INC held its reconvened 2025 Annual General Meeting of Shareholders on September 2, 2025, in Ji'an, Jiangxi, China. The meeting, originally scheduled for August 26, 2025, addressed company business. The company is incorporated in F4 and has a fiscal year end of September 30.
Why It Matters
This filing confirms the completion of the annual shareholder meeting, a routine but important corporate governance event for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine corporate filing confirming a shareholder meeting, with no new financial or operational information provided.
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Filer of the 6-K report
- September 2, 2025 (date) — Date of the reconvened annual general meeting
- August 26, 2025 (date) — Original date of the annual general meeting
- Ji'an, Jiangxi, China (location) — Location of the company's principal executive offices
FAQ
What was the purpose of reconvening the 2025 Annual General Meeting of Shareholders?
The filing states that the meeting was reconvened on September 2, 2025, but does not specify the exact business conducted or the reasons for the reconvening beyond it being the annual general meeting.
When was the original 2025 Annual General Meeting of Shareholders scheduled?
The original 2025 Annual General Meeting of Shareholders was convened on August 26, 2025.
Where are Universe Pharmaceuticals INC's principal executive offices located?
The principal executive offices of Universe Pharmaceuticals INC are located at 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China.
What is Universe Pharmaceuticals INC's fiscal year end?
Universe Pharmaceuticals INC's fiscal year end is September 30.
Does Universe Pharmaceuticals INC file annual reports under Form 20-F or Form 40-F?
Universe Pharmaceuticals INC indicates that it files annual reports under Form 20-F.
Filing Stats: 1,730 words · 7 min read · ~6 pages · Grade level 13.4 · Accepted 2025-09-03 16:10:02
Key Financial Figures
- $11.25 — ch issued Ordinary Share of par value US$11.25 each in the share capital of the Compan
- $0.00001 — f the Company be reduced to par value US$0.00001 each (the “Capital Reduction&rdqu
- $11.24999 — the paid-up capital to the extent of US$11.24999 on each of the then issued Ordinary Sha
- $134,287,453.13338 — ised share capital is altered: from US$134,287,453.13338 divided into: (i) 12,022,495,313,338 or
- $20,000 — hares of par value US$11.25 each; to US$20,000 divided into 2,000,000,000 ordinary sha
- $18,000 — two separate classes as follows: i. US$18,000 divided into 1,800,000,000 class A ordi
- $2,000 — A Ordinary Shares”); and ii. US$2,000 divided into 200,000,000 class B ordina
Filing Documents
- ea0255884-6k_universe.htm (6-K) — 50KB
- 0001213900-25-084040.txt ( ) — 52KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Universe Pharmaceuticals INC. Date: September 3, 2025 By: /s/ Gang Lai Gang Lai Chief Executive Officer 4